Nearly a Third of Clonal Hematopoiesis-Associated DNMT3A Mutations Reduce Protein Stability and May be Associated with Poorer PrognosisYung‐Hsin Huang, Margaret A. Goodell, Joanne I. Hsu et al.|Blood|2018Cited by 2
Clonal Competition: Cisplatin Treatment Drives Dominance of TP53- over Tet2-Mutant Stem Cell ClonesKatharina Wohlan, Margaret A. Goodell, Lorenzo Brunetti et al.|Blood|2022Cited by 1